How do we help biotech founders?

Life science leaders don’t struggle with science.

They struggle with visibility.

Mainly because translating complex research into consistent, market-facing communication takes time, structure and marketing muscle - 3 things most early stage teams don’t have.

Over the years, working with biotech companies, we noticed a pattern:

Founders want to build visibility on platforms like LinkedIn & X

But the process to them like this:

“We should post more”

“What should we talk about?”

“Let’s do it next week” ......and then 3 months pass!

So we built a system to remove that friction.

The BioVerse.Social approach

When a biotech team starts working with us, the goal is not only to “post on LinkedIn.”

The goal is strategic visibility - positioning the company & its founders as credible voices in their domain while supporting business objectives like partnerships, pilot programs, hiring, or fundraising.

To make this practical for busy founders, we run this sprint-style onboarding process.

Step 1: Narrative

Before a single post goes live, we map the story of the company.

This usually includes:

The company narrative

The technology narrative

Industry insights the team can uniquely comment on

For example, a fermentation company might have 3 narrative layers:

The future of precision fermentation

The company’s specific approach to scaling production

Lessons from pilot runs & lab development

This becomes the foundation for all future content.

Without this step, most biotech content becomes random updates.

With it, every post compounds toward authority.

Step 2: Founders

In biotech, people trust people more than logos.

That is why founder profiles often outperform company pages by a wide margin.

We help founders turn their experience into consistent authority-driven content, such as:

Lessons from building the company

Insights from lab progress or pilot programs

Commentary on regulatory or technology developments

Over time, this builds something extremely valuable:

Industry trust.

This is usually what attracts collaborators, investors and early customers.

Step 3: Engagement

Posting content is only half the equation.

The other half is participating in the right conversations.

We actively monitor leading industry discussions relevant to the company.

Then engage with relevant founders, operators, and investors.

This ensures content doesn’t just exist but travels through the right networks.

Step 4: Assets

Biotech teams often have incredible visual material sitting unused:

Lab photos, equipment setups, team images, product samples & conference clips

These assets are gold for storytelling.

During onboarding, we gather and organize them into a content-ready asset library that can power months of posts.

If certain assets don’t exist yet, we help create them intentionally.

Step 5: Execution

Once narrative, assets and access are aligned, we move into execution.

That includes:

Content calendar planning

⬇️

Founder posts

⬇️

Company updates

⬇️

Visual storytelling

⬇️

Performance monitoring

Every few weeks, we review what’s working and adjust.

It's all about building credible visibility over time.

Why does it matter to a biotech company?

A decade ago, biotech visibility was driven almost entirely by:

Conferences / Journal publications / Press releases

Today, founders are increasingly building public industry presence through platforms like LinkedIn & X

This changes how:

Partnerships are formed

Talent discovers the company

Investors are attracted

The labs still matter.

But increasingly, so do the narratives around them.

We help biotech companies translate scientific progress into clear, credible public communication across digital channels. Because great science deserves to be seen.

www.bioverse.social